Skip to main content
Log in

Carrier-Mediated Transport of H1-Antagonist at the Blood-Brain Barrier: A Common Transport System of H1-Antagonists and Lipophilic Basic Drugs

  • Published:
Pharmaceutical Research Aims and scope Submit manuscript

Abstract

The blood-brain barrier (BBB) transport system for H1 antagonists was studied using primary cultured bovine brain capillary endothelial cells (BCEC). The uptake of [3H]mepyramine was inhibited by various H1-antagonists. Ketotifen competitively inhibited [3H]mepyramine uptake with an inhibition constant (Ki ) of 46.8 µM. Lipophilic basic drugs such as propranolol, lidocaine and imipramine significantly inhibited [3H]mepyramine uptake. In particular, propranolol inhibited [3H]mepyramine uptake competitively at an inhibition constant (Ki) of 51.1 µM. Moreover, in ATP-depleted BCEC, [3H]mepyramine uptake was stimulated by preloading with H1- antagonists and lipophilic basic drugs. These results indicated that H1-antagonists are transported across the BBB via a carrier-mediated transport system common to lipophilic basic drugs.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

REFERENCES

  1. Y. Ito, H. Kato, E. Koshinaka, N. Ogawa, H. Nishino and J. Sakaguchi. Piperidine derivatives and pharmaceutical compositions comprising the same. U.S. Patent. 5,095,022 (1992).

  2. M. Yamazaki, H. Fukuoka, O. Nagata, H. Kato, Y. Ito, T. Terasaki and A. Tsuji. Transport mechanism of an H1-antagonist at the blood-brain barrier: Transport mechanism of mepyramine using the carotid injection technique. Biol. Pharm. Bull. 17:676–679 (1994).

    Google Scholar 

  3. M. Yamazaki, T. Terasaki, K. Yoshioka, O. Nagata, H. Kato, Y. Ito and A. Tsuji. Carrier-mediated transport of H1-antagonist at the blood-brain barrier: mepyramine uptake into bovine brain capillary endothelial cells in primary monolayer cultures. Pharm. Res. 11:975–978 (1994).

    Google Scholar 

  4. Y. S. Kang, T. Terasaki, T. Ohnishi and A. Tsuji. In vivo and in vitro evidence for a common carrier mediated transport of choline and basic drugs through the blood-brain barrier. J. PharmacobioDyn. 13:353–360 (1990).

    Google Scholar 

  5. W. M. Pardridge, R. Sakiyama and G. Fidder. Blood-brain barrier transport and brain sequestration of propranolol and lidocaine. Am. J. Physiol. 247:R582–R588 (1984).

    Google Scholar 

  6. A. Kurihara, H. Suzuki, Y. Sawada, Y. Sugiyama, T. Iga and M. Hanano. Uptake of propranolol by microvessels isolated from bovine brain. J. Pharm. Sci. 76:759–764 (1987).

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Yamazaki, M., Terasaki, T., Yoshioka, K. et al. Carrier-Mediated Transport of H1-Antagonist at the Blood-Brain Barrier: A Common Transport System of H1-Antagonists and Lipophilic Basic Drugs. Pharm Res 11, 1516–1518 (1994). https://doi.org/10.1023/A:1018980914687

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1018980914687

Navigation